Optimi Health (OPTH) EBITDA Yield: History & Chart

Optimi Health Corp.(OPTH)

Drug Manufacturers - Specialty & Generic · Princeton, BC

$4.13-0.17 (-3.84%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Optimi Health Corp.

Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.

Princeton, BC

6 employees

www.optimi.net

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dane Stevens

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Optimi Health Corp. (OPTH)	$13.30M	N/A	N/A	N/A	N/A
IN8bio, Inc. (INAB)vs ›	$13.33M	N/A	N/A	N/A	N/A
Citius Pharmaceuticals, Inc. (CTXR)vs ›	$13.20M	N/A	0.87%	0.87%	0.87%
Passage Bio, Inc. (PASG)vs ›	$13.11M	N/A	N/A	N/A	N/A
Obsidian Therapeutics Inc. (OBX)vs ›	$13.75M	N/A	N/A	N/A	N/A
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$12.78M	N/A	N/A	N/A	N/A
Sintx Technologies, Inc. (SINT)vs ›	$13.86M	N/A	N/A	N/A	N/A
Tempest Therapeutics, Inc. (TPST)vs ›	$12.58M	N/A	0.00%	0.00%	0.00%
Pulsenmore Ltd. Ordinary Shares (PLSM)vs ›	$14.05M	N/A	N/A	N/A	N/A
Dare Bioscience, Inc. (DARE)vs ›	$12.48M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

Optimi Health Corp. (OPTH)

$13.30M

N/A

IN8bio, Inc. (INAB)vs ›

$13.33M

N/A

Citius Pharmaceuticals, Inc. (CTXR)vs ›

$13.20M

N/A

0.87%

Passage Bio, Inc. (PASG)vs ›

$13.11M

N/A

Obsidian Therapeutics Inc. (OBX)vs ›

$13.75M

N/A

Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›

$12.78M

N/A

Sintx Technologies, Inc. (SINT)vs ›

$13.86M

N/A

Tempest Therapeutics, Inc. (TPST)vs ›

$12.58M

N/A

0.00%

Pulsenmore Ltd. Ordinary Shares (PLSM)vs ›

$14.05M

N/A

Dare Bioscience, Inc. (DARE)vs ›

$12.48M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

OPTH EBITDA Yield Metrics

OPTH Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics